User profiles for Rotonya Carr
 | Rotonya CarrAssociate Professor of Medicine, University of Washington Verified email at uphs.upenn.edu Cited by 2886 |
A new perspective on NAFLD: Focusing on lipid droplets
E Scorletti, RM Carr - Journal of hepatology, 2022 - Elsevier
Lipid droplets (LDs) are complex and metabolically active organelles. They are composed
of a neutral lipid core surrounded by a monolayer of phospholipids and proteins. LD …
of a neutral lipid core surrounded by a monolayer of phospholipids and proteins. LD …
Nonalcoholic fatty liver disease: pathophysiology and management
Nonalcoholic fatty liver disease (NAFLD) is a clinical diagnosis that includes the presence
of 5% or more hepatic steatosis as determined by liver imaging or biopsy in the absence of …
of 5% or more hepatic steatosis as determined by liver imaging or biopsy in the absence of …
Predictors of outcomes of COVID-19 in patients with chronic liver disease: US multi-center study
…, AS Vogel, AM Catana, K Wegermann, RM Carr… - Clinical …, 2021 - Elsevier
Background & Aims Chronic liver disease (CLD) represents a major global health burden.
We undertook this study to identify the factors associated with adverse outcomes in patients …
We undertook this study to identify the factors associated with adverse outcomes in patients …
Pathophysiology of lipid droplet proteins in liver diseases
Cytosolic lipid droplets (LDs) are present in most cell types, and consist of a core comprising
neutral lipids, mainly triglycerides and sterol esters, surrounded by a monolayer of …
neutral lipids, mainly triglycerides and sterol esters, surrounded by a monolayer of …
A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological …
Nonalcoholic fatty liver disease (NAFLD) is a growing cause of chronic liver disease. Using
a proxy NAFLD definition of chronic elevation of alanine aminotransferase (cALT) levels …
a proxy NAFLD definition of chronic elevation of alanine aminotransferase (cALT) levels …
[HTML][HTML] Alcohol effects on hepatic lipid metabolism
Alcoholic liver disease (ALD) is the most prevalent type of chronic liver disease with
significant morbidity and mortality worldwide. ALD begins with simple hepatic steatosis and …
significant morbidity and mortality worldwide. ALD begins with simple hepatic steatosis and …
Academic careers and the COVID-19 pandemic: reversing the tide
The COVID-19 pandemic halted research operations at academic medical centers. This
shutdown has adversely affected research infrastructure, the current research workforce, and the …
shutdown has adversely affected research infrastructure, the current research workforce, and the …
Outcome of COVID‐19 in patients with autoimmune hepatitis: an international multicenter study
Background and Aims Data regarding outcome of COVID‐19 in patients with autoimmune
hepatitis (AIH) are lacking. Approach and Results We performed a retrospective study on …
hepatitis (AIH) are lacking. Approach and Results We performed a retrospective study on …
FXR agonists as therapeutic agents for non-alcoholic fatty liver disease
RM Carr, AE Reid - Current atherosclerosis reports, 2015 - Springer
Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic
syndrome and a risk factor for both cardiovascular and hepatic related morbidity and mortality. …
syndrome and a risk factor for both cardiovascular and hepatic related morbidity and mortality. …
FXR-dependent modulation of the human small intestinal microbiome by the bile acid derivative obeticholic acid
… Luciano Adorini, Farah Babakhani, Jeffrey Edwards, and Rotonya M. Carr reviewed and
edited the manuscript. Gary D. Wu, Luciano Adorini, Farah Babakhani, and David Shapiro …
edited the manuscript. Gary D. Wu, Luciano Adorini, Farah Babakhani, and David Shapiro …
